Advertisement

Pulmonology

Home Pulmonology
Guidelines for doctors on how to prescribe two antimalarial drugs that some believe may treat the novel coronavirus are no longer available on the U.S. Centers for Disease Control and Prevention website.

CDC Removes Prescribing Guidelines for Antimalarial Drugs

Guidance statement is now shorter than the previous version and no longer provides dosage information
Children with coronavirus disease 2019 have symptoms of fever

Children With COVID-19 Do Not Always Have Cough, Fever

73 percent of children had fever, cough, shortness of breath versus 93 percent of adults age 18 to 64
Children diagnosed with COVID-19 have a milder disease course and better prognoses than adults

Children Have Milder Disease Course, Better COVID-19 Prognosis

Diagnostic presentation has been similar to that of adults, but with less severe pneumonia
Patients with celiac disease have a small but statistically significantly increased mortality risk compared with controls

Celiac Disease May Slightly Increase Mortality Risk

Increased risk seen for overall mortality and cardiovascular-, cancer-, and respiratory-related death
In guidelines issued by the international Surviving Sepsis Campaign initiative

Guidelines Developed for COVID-19 Patients in ICU

54 statements issued on infection control, diagnosis, hemodynamic support, ventilator support, therapy
Baseline modifiable electronic cigarette device users smoke more cigarettes at one-year follow-up than vape pen users

‘Mod’ E-Cigarette Users Smoke More Cigarettes One Year Later

Those who use mods versus vape pens smoke more than six times as many cigarettes at one-year follow-up
The use of the antimalarial drug chloroquine to treat COVID-19 patients has been halted at several Swedish hospitals due to reported side effects such as cramps and loss of peripheral vision. Sahlgrenska University Hospital is one of those facilities. It stopped the use of chloroquine in the treatment of COVID-19 about two weeks ago.

Side Effects Seen With Use of Chloroquine Against COVID-19

Some Swedish hospitals have stopped using the antimalarial drug due to severity of side effects
When hypothetical stay-at-home orders in response to COVID-19 are extended longer than expected

Compliance Higher if Stay-at-Home Extensions Are Shorter Than Thought

Results more pronounced among individuals who were already fully complying with self-isolation
Serious concerns are associated with coronavirus disease 2019

Serious Concerns Associated With COVID-19 Pandemic Reported

Respondents report difficulty obtaining hand sanitizer, food, childcare; concerns include getting sick
Extracorporeal membrane oxygenation support might improve clinical outcomes in severe cases of coronavirus disease 2019 that cannot be adequately managed with mechanical ventilation alone

Extracorporeal Membrane Oxygenation Might Aid in Severe COVID-19

Three of eight patients receiving ECMO support successfully weaned off ECMO after 22, 40, 47 days